Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 1.8. It has been cited 42 times, with 33 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
1.2
From 28 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 33 citers.
National Institutes of Health
Grant: 5-T32 HL007604
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK102511
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R03DK122240
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: U01DK096189
Amgen
AstraZeneca
Boehringer Ingelheim
Servier
Cytokinetics
GlaxoSmithKline
National Heart, Lung, and Blood Institute
Sanofi
Celladon Corporation
Gilead Sciences
Ionis Pharmaceuticals
Novo Nordisk
Takeda Pharmaceuticals U.S.A.
Bayer Fund
Bristol-Myers Squibb
MyoKardia
Novartis
Sanofi Pasteur
Abbott Laboratories
Boston Scientific Corporation
Jazz Pharmaceuticals
MeSH Terms
Keywords